Lecturer
Email : This email address is being protected from spambots. You need JavaScript enabled to view it.
MRCP (UK)
Publications (in the last 3 years)
(a) Kityo C, Walker AS, Dickinson L, Lutwama F, Kayiwa J, Ssali F, Nalumenya R, Tumukunde D, Munderi P, Reid A, Gilks CF, Gibb DM, Khoo S; DART Trial Team. Pharmacokinetics of lopinavir-ritonavir with and without nonnucleoside reverse transcriptase inhibitors in Ugandan HIV-infected adults. Antimicrobial Agents & Chemotherapy 2010 Jul; 54(7):2965-73. Epub 2010 Apr 26
(b) Walker AS, Ford D, Gilks C, Munderi P, Ssali F, Reid A, Katabira E, Grosskurth H, Mugyenyi P, Hakim J, Darbyshire JH, Gibb DM, Babiker AG. Daily cotrimoxazole prophylaxis in severely immunosuppressed adults in Africa started on combination antiretroviral therapy. Lancet 2010 Apr 10; 375(9722):1278-86. Epub 2010 Mar 27
(c) Munderi P, Walker AS, Kityo C, Babiker AG, Ssali F, Reid A, Darbyshire JH, Grosskurth H, P Mugyenyi, Gibb DM, Gilks CF on behalf of the DART/NORA trial teams. Nevirapine/zidovudine/lamivudine has superior immunological and virological responses not reflected in clinical outcomes in a 48 week randomised comparison with abacavir/zidovudine/lamivudine in HIV-infected Ugandan adults with low CD4 counts. HIV Medicine 2010 May; 11(5):334-44. Epub 2010 Feb 3
